InvestSMART

Orthocell Limited (ASX: OCC) - Announcements

Current share price for OCC : $0.550 0.015 (2.80%)+

ASX company news and announcements for Orthocell Limited (OCC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Orthocell Limited (OCC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Orthocell Limited (OCC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Orthocell Limited (OCC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$150 Application for quotation of securities - OCC 15 Oct 2024 3:07PM $0.720 $0.550 fallen by 23.61%
$150 Regulatory approval to commence Remplir sales in Singapore 8 Oct 2024 9:32AM $0.480 $0.550 risen by 14.58%
$150 Trading Halt 7 Oct 2024 3:44PM $0.480 $0.550 risen by 14.58%
$150 Pause in Trading 7 Oct 2024 3:04PM $0.480 $0.550 risen by 14.58%
$150 Second Consecutive Record Quarter as Revenue Exceeds $2m 7 Oct 2024 8:56AM $0.460 $0.550 risen by 19.57%
$150 Date of AGM & Closing Date for Director Nominations 4 Oct 2024 8:22AM $0.455 $0.550 risen by 20.88%
$150 Notification of cessation of securities - OCC 17 Sep 2024 8:24AM $0.465 $0.550 risen by 18.28%
$150 Further regarding Company Presentation 11 Sep 2024 9:07AM $0.460 $0.550 risen by 19.57%
$150 First sales of Striate in major new market of Canada 6 Sep 2024 8:53AM $0.390 $0.550 risen by 41.03%
$150 Appendix 4G 30 Aug 2024 1:49PM $0.378 $0.550 risen by 45.70%
$150 Corporate Governance Statement 30 Aug 2024 1:49PM $0.378 $0.550 risen by 45.70%
$150 Appendix 4E & Annual Report 30 Aug 2024 1:49PM $0.378 $0.550 risen by 45.70%
$150 Company Presentation 30 Aug 2024 9:36AM $0.380 $0.550 risen by 44.74%
$150 Notification regarding unquoted securities - OCC 8 Aug 2024 5:31PM $0.390 $0.550 risen by 41.03%
$150 Application for quotation of securities - OCC 8 Aug 2024 5:28PM $0.390 $0.550 risen by 41.03%
$150 Striate Expansion Continues with Singapore Application 29 Jul 2024 9:01AM $0.385 $0.550 risen by 42.86%
$150 Global Market Expansion Accelerates - New Regions Pending 24 Jul 2024 8:58AM $0.375 $0.550 risen by 46.67%
$150 Quarterly Activity Report & Appendix 4C 16 Jul 2024 9:33AM $0.395 $0.550 risen by 39.24%
$150 Regulatory Approval to Commence Sales for Striate in Canada 11 Jul 2024 9:37AM $0.370 $0.550 risen by 48.65%
$150 Trading Halt 10 Jul 2024 11:00AM $0.370 $0.550 risen by 48.65%
$150 Pause in Trading 10 Jul 2024 10:46AM $0.370 $0.550 risen by 48.65%
$150 Record Quarterly and Yearly Revenue Show Outstanding Growth 9 Jul 2024 9:05AM $0.365 $0.550 risen by 50.68%
$150 Notification regarding unquoted securities - OCC 12 Jun 2024 8:24AM $0.360 $0.550 risen by 52.78%
$150 Proposed issue of securities - OCC 11 Jun 2024 3:58PM $0.365 $0.550 risen by 50.68%
$150 Third Revenue Generating Product to be Launched in SmrtGraft 11 Jun 2024 8:56AM $0.360 $0.550 risen by 52.78%

201 - 225 of 775 results

Page 9 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.